Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers
Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglyc...
Ausführliche Beschreibung
Autor*in: |
Cena, Hellas [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2013 |
---|
Schlagwörter: |
---|
Anmerkung: |
© Cena et al.; licensee BioMed Central Ltd. 2013 |
---|
Übergeordnetes Werk: |
Enthalten in: Diabetology & metabolic syndrome - London : BioMed Central, 2009, 5(2013), 1 vom: 30. Mai |
---|---|
Übergeordnetes Werk: |
volume:5 ; year:2013 ; number:1 ; day:30 ; month:05 |
Links: |
---|
DOI / URN: |
10.1186/1758-5996-5-28 |
---|
Katalog-ID: |
SPR030240395 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | SPR030240395 | ||
003 | DE-627 | ||
005 | 20230519143130.0 | ||
007 | cr uuu---uuuuu | ||
008 | 201007s2013 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/1758-5996-5-28 |2 doi | |
035 | |a (DE-627)SPR030240395 | ||
035 | |a (SPR)1758-5996-5-28-e | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cena, Hellas |e verfasserin |4 aut | |
245 | 1 | 0 | |a Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers |
264 | 1 | |c 2013 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a © Cena et al.; licensee BioMed Central Ltd. 2013 | ||
520 | |a Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age. | ||
650 | 4 | |a Metabolic syndrome |7 (dpeaa)DE-He213 | |
650 | 4 | |a Smoking habit |7 (dpeaa)DE-He213 | |
650 | 4 | |a Insulin resistance |7 (dpeaa)DE-He213 | |
650 | 4 | |a Overweight |7 (dpeaa)DE-He213 | |
650 | 4 | |a Waist circumference |7 (dpeaa)DE-He213 | |
700 | 1 | |a Tesone, Antonella |4 aut | |
700 | 1 | |a Niniano, Rosanna |4 aut | |
700 | 1 | |a Cerveri, Isa |4 aut | |
700 | 1 | |a Roggi, Carla |4 aut | |
700 | 1 | |a Turconi, Giovanna |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Diabetology & metabolic syndrome |d London : BioMed Central, 2009 |g 5(2013), 1 vom: 30. Mai |w (DE-627)610606689 |w (DE-600)2518786-7 |x 1758-5996 |7 nnns |
773 | 1 | 8 | |g volume:5 |g year:2013 |g number:1 |g day:30 |g month:05 |
856 | 4 | 0 | |u https://dx.doi.org/10.1186/1758-5996-5-28 |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_SPRINGER | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2055 | ||
912 | |a GBV_ILN_2111 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 5 |j 2013 |e 1 |b 30 |c 05 |
author_variant |
h c hc a t at r n rn i c ic c r cr g t gt |
---|---|
matchkey_str |
article:17585996:2013----::rvlneaefeaoisnrmiaruol |
hierarchy_sort_str |
2013 |
publishDate |
2013 |
allfields |
10.1186/1758-5996-5-28 doi (DE-627)SPR030240395 (SPR)1758-5996-5-28-e DE-627 ger DE-627 rakwb eng Cena, Hellas verfasserin aut Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Cena et al.; licensee BioMed Central Ltd. 2013 Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age. Metabolic syndrome (dpeaa)DE-He213 Smoking habit (dpeaa)DE-He213 Insulin resistance (dpeaa)DE-He213 Overweight (dpeaa)DE-He213 Waist circumference (dpeaa)DE-He213 Tesone, Antonella aut Niniano, Rosanna aut Cerveri, Isa aut Roggi, Carla aut Turconi, Giovanna aut Enthalten in Diabetology & metabolic syndrome London : BioMed Central, 2009 5(2013), 1 vom: 30. Mai (DE-627)610606689 (DE-600)2518786-7 1758-5996 nnns volume:5 year:2013 number:1 day:30 month:05 https://dx.doi.org/10.1186/1758-5996-5-28 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 5 2013 1 30 05 |
spelling |
10.1186/1758-5996-5-28 doi (DE-627)SPR030240395 (SPR)1758-5996-5-28-e DE-627 ger DE-627 rakwb eng Cena, Hellas verfasserin aut Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Cena et al.; licensee BioMed Central Ltd. 2013 Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age. Metabolic syndrome (dpeaa)DE-He213 Smoking habit (dpeaa)DE-He213 Insulin resistance (dpeaa)DE-He213 Overweight (dpeaa)DE-He213 Waist circumference (dpeaa)DE-He213 Tesone, Antonella aut Niniano, Rosanna aut Cerveri, Isa aut Roggi, Carla aut Turconi, Giovanna aut Enthalten in Diabetology & metabolic syndrome London : BioMed Central, 2009 5(2013), 1 vom: 30. Mai (DE-627)610606689 (DE-600)2518786-7 1758-5996 nnns volume:5 year:2013 number:1 day:30 month:05 https://dx.doi.org/10.1186/1758-5996-5-28 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 5 2013 1 30 05 |
allfields_unstemmed |
10.1186/1758-5996-5-28 doi (DE-627)SPR030240395 (SPR)1758-5996-5-28-e DE-627 ger DE-627 rakwb eng Cena, Hellas verfasserin aut Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Cena et al.; licensee BioMed Central Ltd. 2013 Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age. Metabolic syndrome (dpeaa)DE-He213 Smoking habit (dpeaa)DE-He213 Insulin resistance (dpeaa)DE-He213 Overweight (dpeaa)DE-He213 Waist circumference (dpeaa)DE-He213 Tesone, Antonella aut Niniano, Rosanna aut Cerveri, Isa aut Roggi, Carla aut Turconi, Giovanna aut Enthalten in Diabetology & metabolic syndrome London : BioMed Central, 2009 5(2013), 1 vom: 30. Mai (DE-627)610606689 (DE-600)2518786-7 1758-5996 nnns volume:5 year:2013 number:1 day:30 month:05 https://dx.doi.org/10.1186/1758-5996-5-28 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 5 2013 1 30 05 |
allfieldsGer |
10.1186/1758-5996-5-28 doi (DE-627)SPR030240395 (SPR)1758-5996-5-28-e DE-627 ger DE-627 rakwb eng Cena, Hellas verfasserin aut Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Cena et al.; licensee BioMed Central Ltd. 2013 Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age. Metabolic syndrome (dpeaa)DE-He213 Smoking habit (dpeaa)DE-He213 Insulin resistance (dpeaa)DE-He213 Overweight (dpeaa)DE-He213 Waist circumference (dpeaa)DE-He213 Tesone, Antonella aut Niniano, Rosanna aut Cerveri, Isa aut Roggi, Carla aut Turconi, Giovanna aut Enthalten in Diabetology & metabolic syndrome London : BioMed Central, 2009 5(2013), 1 vom: 30. Mai (DE-627)610606689 (DE-600)2518786-7 1758-5996 nnns volume:5 year:2013 number:1 day:30 month:05 https://dx.doi.org/10.1186/1758-5996-5-28 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 5 2013 1 30 05 |
allfieldsSound |
10.1186/1758-5996-5-28 doi (DE-627)SPR030240395 (SPR)1758-5996-5-28-e DE-627 ger DE-627 rakwb eng Cena, Hellas verfasserin aut Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers 2013 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Cena et al.; licensee BioMed Central Ltd. 2013 Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age. Metabolic syndrome (dpeaa)DE-He213 Smoking habit (dpeaa)DE-He213 Insulin resistance (dpeaa)DE-He213 Overweight (dpeaa)DE-He213 Waist circumference (dpeaa)DE-He213 Tesone, Antonella aut Niniano, Rosanna aut Cerveri, Isa aut Roggi, Carla aut Turconi, Giovanna aut Enthalten in Diabetology & metabolic syndrome London : BioMed Central, 2009 5(2013), 1 vom: 30. Mai (DE-627)610606689 (DE-600)2518786-7 1758-5996 nnns volume:5 year:2013 number:1 day:30 month:05 https://dx.doi.org/10.1186/1758-5996-5-28 kostenfrei Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 5 2013 1 30 05 |
language |
English |
source |
Enthalten in Diabetology & metabolic syndrome 5(2013), 1 vom: 30. Mai volume:5 year:2013 number:1 day:30 month:05 |
sourceStr |
Enthalten in Diabetology & metabolic syndrome 5(2013), 1 vom: 30. Mai volume:5 year:2013 number:1 day:30 month:05 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
Metabolic syndrome Smoking habit Insulin resistance Overweight Waist circumference |
isfreeaccess_bool |
true |
container_title |
Diabetology & metabolic syndrome |
authorswithroles_txt_mv |
Cena, Hellas @@aut@@ Tesone, Antonella @@aut@@ Niniano, Rosanna @@aut@@ Cerveri, Isa @@aut@@ Roggi, Carla @@aut@@ Turconi, Giovanna @@aut@@ |
publishDateDaySort_date |
2013-05-30T00:00:00Z |
hierarchy_top_id |
610606689 |
id |
SPR030240395 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR030240395</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519143130.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/1758-5996-5-28</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR030240395</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)1758-5996-5-28-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cena, Hellas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Cena et al.; licensee BioMed Central Ltd. 2013</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metabolic syndrome</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Smoking habit</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Insulin resistance</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Overweight</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Waist circumference</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tesone, Antonella</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Niniano, Rosanna</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cerveri, Isa</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Roggi, Carla</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Turconi, Giovanna</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Diabetology & metabolic syndrome</subfield><subfield code="d">London : BioMed Central, 2009</subfield><subfield code="g">5(2013), 1 vom: 30. Mai</subfield><subfield code="w">(DE-627)610606689</subfield><subfield code="w">(DE-600)2518786-7</subfield><subfield code="x">1758-5996</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:5</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">day:30</subfield><subfield code="g">month:05</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/1758-5996-5-28</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">5</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="b">30</subfield><subfield code="c">05</subfield></datafield></record></collection>
|
author |
Cena, Hellas |
spellingShingle |
Cena, Hellas misc Metabolic syndrome misc Smoking habit misc Insulin resistance misc Overweight misc Waist circumference Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers |
authorStr |
Cena, Hellas |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)610606689 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut |
collection |
springer |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
1758-5996 |
topic_title |
Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers Metabolic syndrome (dpeaa)DE-He213 Smoking habit (dpeaa)DE-He213 Insulin resistance (dpeaa)DE-He213 Overweight (dpeaa)DE-He213 Waist circumference (dpeaa)DE-He213 |
topic |
misc Metabolic syndrome misc Smoking habit misc Insulin resistance misc Overweight misc Waist circumference |
topic_unstemmed |
misc Metabolic syndrome misc Smoking habit misc Insulin resistance misc Overweight misc Waist circumference |
topic_browse |
misc Metabolic syndrome misc Smoking habit misc Insulin resistance misc Overweight misc Waist circumference |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Diabetology & metabolic syndrome |
hierarchy_parent_id |
610606689 |
hierarchy_top_title |
Diabetology & metabolic syndrome |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)610606689 (DE-600)2518786-7 |
title |
Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers |
ctrlnum |
(DE-627)SPR030240395 (SPR)1758-5996-5-28-e |
title_full |
Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers |
author_sort |
Cena, Hellas |
journal |
Diabetology & metabolic syndrome |
journalStr |
Diabetology & metabolic syndrome |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2013 |
contenttype_str_mv |
txt |
author_browse |
Cena, Hellas Tesone, Antonella Niniano, Rosanna Cerveri, Isa Roggi, Carla Turconi, Giovanna |
container_volume |
5 |
format_se |
Elektronische Aufsätze |
author-letter |
Cena, Hellas |
doi_str_mv |
10.1186/1758-5996-5-28 |
title_sort |
prevalence rate of metabolic syndrome in a group of light and heavy smokers |
title_auth |
Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers |
abstract |
Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age. © Cena et al.; licensee BioMed Central Ltd. 2013 |
abstractGer |
Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age. © Cena et al.; licensee BioMed Central Ltd. 2013 |
abstract_unstemmed |
Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age. © Cena et al.; licensee BioMed Central Ltd. 2013 |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_11 GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_73 GBV_ILN_74 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2003 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
1 |
title_short |
Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers |
url |
https://dx.doi.org/10.1186/1758-5996-5-28 |
remote_bool |
true |
author2 |
Tesone, Antonella Niniano, Rosanna Cerveri, Isa Roggi, Carla Turconi, Giovanna |
author2Str |
Tesone, Antonella Niniano, Rosanna Cerveri, Isa Roggi, Carla Turconi, Giovanna |
ppnlink |
610606689 |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.1186/1758-5996-5-28 |
up_date |
2024-07-03T14:53:24.542Z |
_version_ |
1803570018578857984 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR030240395</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519143130.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s2013 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1186/1758-5996-5-28</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR030240395</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)1758-5996-5-28-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cena, Hellas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Prevalence rate of Metabolic Syndrome in a group of light and heavy smokers</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Cena et al.; licensee BioMed Central Ltd. 2013</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background Smoking is an important cause of morbidity and mortality worldwide. It iswidely accepted as a major risk factor for metabolic and cardiovasculardisease. Smoking reduces insulin sensitivity or induces insulin resistanceand enhances cardiovascular risk factors such as elevated plasmatriglycerides, decreases high-density lipoprotein cholesterol and causeshyperglycemia. Several studies show that smoking is associated withmetabolic abnormalities and increases the risk of Metabolic Syndrome. Theaim of this study was to estimate the prevalence of the metabolic syndromein a group of light and heavy smokers, wishing to give up smoking. Methods In this cross-sectional study all the enrolled subjects voluntary joined thesmoking cessation program held by the Respiratory Pathophysiology Unit ofSan Matteo Hospital, Pavia, Northern Italy. All the subjects enrolled were former smokers from at least 10 years and hadno cancer or psychiatric disorders, nor history of diabetes or CVD orcoronary artery disease and were not on any medication. Results The subjects smoke 32.3 ± 16.5 mean Pack Years. Theprevalence of the metabolic syndrome is 52.1%: 57.3% and 44.9% for males andfemales respectively. Analysing the smoking habit influence on the IDFcriteria for the metabolic syndrome diagnosis we found that all thevariables show an increasing trend from light to heavy smokers, except forHDL cholesterol. A statistical significant correlation among Pack Years andwaist circumference (R = 0.48, p < 0.0001),Systolic Blood Pressure (R = 0.18, p < 0.05),fasting plasma glucose (R = 0.19, p < 0.005) andHDL cholesterol (R = −0.26, p = 0.0005) hasbeen observed. Conclusions Currently smoking subjects are at high risk of developing the metabolicsyndrome. Therapeutic lifestyle changes, including smoking cessation are a desirablePublic health goal and should successfully be implemented in clinicalpractice at any age.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Metabolic syndrome</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Smoking habit</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Insulin resistance</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Overweight</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Waist circumference</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tesone, Antonella</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Niniano, Rosanna</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cerveri, Isa</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Roggi, Carla</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Turconi, Giovanna</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Diabetology & metabolic syndrome</subfield><subfield code="d">London : BioMed Central, 2009</subfield><subfield code="g">5(2013), 1 vom: 30. Mai</subfield><subfield code="w">(DE-627)610606689</subfield><subfield code="w">(DE-600)2518786-7</subfield><subfield code="x">1758-5996</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:5</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:1</subfield><subfield code="g">day:30</subfield><subfield code="g">month:05</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1186/1758-5996-5-28</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">5</subfield><subfield code="j">2013</subfield><subfield code="e">1</subfield><subfield code="b">30</subfield><subfield code="c">05</subfield></datafield></record></collection>
|
score |
7.399906 |